Oulu (Finland), Munich (Germany)
michael.braun@berggren.fi +358 10 227 2121 +358 45 7820 3003 Michael Braun Contact meEducation
Dr. rer. nat. (chemistry), UPC Representative, European Patent Attorney, European Trademark and Design Attorney
Technical fields
Life Sciences, Chemistry & Materials
Specializations
Patent prosecution, opposition and appeal proceedings in the fields of organic, inorganic and technical chemistry, polymer chemistry, catalysis, pharmaceuticals, membranes and biotechnology.
Languages
German, English
Michael Braun
German and European Patent Attorney
Partner
•IP Expert since 2011
Dr. Michael Braun is a partner and German and European Patent Attorney at Berggren, and has worked in IP since 2011. His practice centers on matters where the stakes and technical difficulty are highest: prosecution files that have proven hard to move forward, oppositions and appeals, and infringement and validity disputes before the Unified Patent Court and the German courts.
Our clients come to Michael to have a difficult case assessed realistically, to identify risks and opportunities early, and to have their innovations protected in a way that holds up when tested. He works across chemistry, materials science, pharmaceuticals, biotech, process engineering, physics, foundational technologies and general engineering, drawing on his training as a chemist and his doctorate in a physics-based field to follow an invention wherever the technology leads.
Before joining Berggren, Michael practiced at a leading German IP firm, where he handled prosecution and contentious matters for European and international clients.
Michael is appreciated by our clients for his skills in patent prosecution, oppositions, appeals, and disputes before the UPC and German courts.
Memberships in professional associations
Patentanwaltskammer (German Patent Attorney Bar Association)
epi
FICPI
VPP
LESI
Recent Posts By Michael Braun
German Federal Court of Justice inches closer to EPO approach to novelty and applies EPO’s standard on priority claims from G1/22 and G2/22
In the landmark case "Sorafenib-Tosylat" decided 28 November 2023 (X ZR 83/21), the German Federal...
Read more
First Pan-European Preliminary Injunction Granted by the Unified Patent Court
The first inter partes preliminary injunction for a European Patent with unitary effect (“Unitary...
Read more
Weshalb Konsistenz zwischen Beispielen und Ansprüchen zur Robustheit eines europäisches Patents gegen Angriffe beitragen kann
inwieweit kann eine Regel, die im Kontext eines Vergleichs zwischen Patent und Stand der Technik...
Read more
Practice Tips at the EPO Relating to Numerical Ranges in Examples and Claims
To what extent can a rule developed in the context of comparing numerical values of a patent claim...
Read more
Berggren Series on 2022 EPO Guideline Revisions: Updates on partial priority law
This is the second article in our 2022 weekly series addressing updates to the European Patent...
Read more
First come, first served: EUIPO launches limited SME fund for 2022
Small and medium-sized enterprises (SMEs) based in the EU can now apply for the “Ideas Powered for...
Read more
Germany: Liberalization of regulations for patent attorneys enters into force in August 2022
In the past, the possibilities with regard to corporate organization for German patent attorneys...
Read more